Streamlining Your NCA Workflow
PK analysis intended for submission contends with many data and compliance challenges. To work efficiently,…
CertaraJanuary 18, 2024
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database
To assess real-world treatment patterns in patients diagnosed with hormone receptor positive (HR+), human epidermal…
CertaraJanuary 17, 2024
Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission
Join our webinar to explore best practices for harnessing the power of standards, without a…
CertaraJanuary 16, 2024
Real-world application of PBPK in drug discovery
The utility of PBPK models in support of drug development has been well documented. During…
CertaraJanuary 11, 2024
Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.
What does it take to industrialize QSP? What is the right mix of technology and…
CertaraJanuary 9, 2024
MedCity News | How the IRA Has Created a New Environment for Biosimilars
By Maximillian Vargas and Caitlin Verrilli As IRA provisions are activated, the law’s impact on…
CertaraJanuary 5, 2024
Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024
By Clinical Research Team We spoke with leaders and experts in the Clinical Research community…
CertaraJanuary 5, 2024
Bio-IT World | Trendspotting: What’s Coming for Biotech in 2024
By Bio-IT World Team To kick off the New Year, we spoke with leaders and…
CertaraJanuary 5, 2024
Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations
This mini-review provides a concise and comprehensive overview of the pregnancy PBPK field and identify…
CertaraJanuary 3, 2024
